OGIVRI

trastuzumab-dkst · Biocon Biologics Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for OGIVRI, covering 2017-11-28 to 2026-02-23. Get the full timeline:

Most recent: EMA Authorised: Ogivri (trastuzumab) — Biosimilar Collaborations Ireland Limited